earnings

Busy with 3 program launches this year, Biogen trims pipeline
Fierce Biotech
Tue, 04/25/23 - 11:40 am
Biogen
stroke
gene therapy
ophthalmology
earnings
Novartis, helped by cost cuts, raises full-year outlook
Reuters
Tue, 04/25/23 - 10:47 am
Novartis
earnings
Why Medtronic Stock Soared More Than 4% Higher Today
Motley Fool
Wed, 04/19/23 - 09:45 pm
Medtronic
Medtech
earnings
Abbott sales 18% fall due to anticipation of COVID testing sales declines
Medical Marketing and Media
Wed, 04/19/23 - 11:34 am
Abbott Labs
earnings
COVID-19
Medtech
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
Tue, 04/18/23 - 10:13 am
JNJ
Janssen
earnings
restructuring
infectious disease
Regeneron expects $56M IPR&D charge tied to cell therapy pact
Fierce Biotech
Mon, 04/10/23 - 04:53 pm
Regeneron
earnings
R&D
Sonoma Biotherapeutics
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
Biopharma Reporter
Mon, 03/27/23 - 10:19 am
BioNTech
earnings
COVID-19
vaccines
Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023
Fierce Pharma
Tue, 02/28/23 - 10:41 pm
Bayer
earnings
Eylea
BeiGene doubles sales as Brukinsa, tislelizumab gear up for key launches
Fierce Pharma
Mon, 02/27/23 - 07:06 pm
BeiGene
Brukinsa
earnings
tislelizumab
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Investors Business Daily
Thu, 02/23/23 - 10:38 am
Moderna Therapeutics
earnings
MRNA
vaccines
FDA
cancer vaccines
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
Motley Fool
Thu, 02/23/23 - 10:30 am
Pfizer
earnings
vaccines
COVID-19
Medtronic boosts full-year outlook as supply challenges subside
Medtech Dive
Wed, 02/22/23 - 09:48 am
Medtronic
Medtech
devices
earnings
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Thu, 02/16/23 - 11:27 am
Seagen
earnings
Merck
M&A
Adcetris
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
Endpoints
Wed, 02/15/23 - 06:30 pm
Biogen
InnoCare Pharma
orelabrutinib
earnings
Lower COVID sales weigh on AZ in fourth quarter
Pharmaphorum
Thu, 02/9/23 - 10:51 am
AstraZeneca
COVID-19
vaccines
earnings
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
PharmaLive
Thu, 02/9/23 - 10:35 am
Teva Pharmaceutical
earnings
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Fierce Pharma
Mon, 02/6/23 - 10:58 am
Sanofi
Dupixent
earnings
In showdown with Roche, Regeneron gears up for potential Eylea expansion amid Covid decline
Endpoints
Mon, 02/6/23 - 10:35 am
Regeneron
earnings
Eylea
Oncology, HIV sales lift Gilead’s revenues by 2%
Medical Marketing and Media
Thu, 02/2/23 - 11:09 pm
Gilead Sciences
earnings
HIV
oncology
hepatitis C
Medtech earnings reports: insights from major players' Q4 results
CP Wire
Thu, 02/2/23 - 01:29 pm
Medtech
devices
earnings
Edwards Lifesciences
Stryker
Boston Scientific
Siemens Healthineers

Pages